Literature DB >> 20629667

Visual signs and symptoms of progressive supranuclear palsy.

Richard A Armstrong1.   

Abstract

Progressive supranuclear palsy is a rare, degenerative brain disorder and the second most common syndrome in which the patient exhibits 'parkinsonism', that is, a variety of symptoms involving problems with movement. General symptoms include difficulties with gait and balance; the patient walking clumsily and often falling backwards. The syndrome can be difficult to diagnose and visual signs and symptoms can help to separate it from closely related movement disorders such as Parkinson's disease, multiple system atrophy, dementia with Lewy bodies and corticobasal degeneration. A combination of the presence of vertical supranuclear gaze palsy, fixation instability, lid retraction, blepharospasm and apraxia of eyelid opening and closing may be useful visual signs in the identification of progressive supranuclear palsy. As primary eye-care practitioners, optometrists should be able to identify the visual problems of patients with this disorder and be expected to work with patients and their carers to manage their visual welfare.
© 2010 The Author. Journal compilation © 2010 Optometrists Association Australia.

Entities:  

Mesh:

Year:  2011        PMID: 20629667     DOI: 10.1111/j.1444-0938.2010.00504.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  9 in total

1.  Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.

Authors:  Brittany N Dugger; Michael Tu; Melissa E Murray; Dennis W Dickson
Journal:  Neurosci Lett       Date:  2011-01-12       Impact factor: 3.046

2.  Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.

Authors:  Tien Dam; Adam L Boxer; Lawrence I Golbe; Günter U Höglinger; Huw R Morris; Irene Litvan; Anthony E Lang; Jean-Christophe Corvol; Ikuko Aiba; Michael Grundman; Lili Yang; Beth Tidemann-Miller; Joseph Kupferman; Kristine Harper; Kubra Kamisoglu; Michael J Wald; Danielle L Graham; Liz Gedney; John O'Gorman; Samantha Budd Haeberlein
Journal:  Nat Med       Date:  2021-08-12       Impact factor: 87.241

Review 3.  Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.

Authors:  Elan D Louis; Rachel Babij; Karen Ma; Etty Cortés; Jean-Paul G Vonsattel
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

Review 4.  Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review.

Authors:  Bernhard A Sabel; Josef Flammer; Lotfi B Merabet
Journal:  Restor Neurol Neurosci       Date:  2018       Impact factor: 2.406

Review 5.  Complex dystonias: an update on diagnosis and care.

Authors:  Rebecca Herzog; Anne Weissbach; Tobias Bäumer; Alexander Münchau
Journal:  J Neural Transm (Vienna)       Date:  2020-11-13       Impact factor: 3.575

6.  Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.

Authors:  Annette Janzen; Douglas P Munoz; Mahboubeh Habibi; Wolfgang H Oertel; Brian J White; Donald C Brien; Brian C Coe; Heidi C Riek; Julia Perkins; Rachel Yep; Laurent Itti; Lars Timmermann; Christoph Best; Elisabeth Sittig
Journal:  J Neurol       Date:  2022-04-30       Impact factor: 6.682

7.  Immunohistochemical Study of Mitochondrial Ferritin in the Midbrain of Patients with Progressive Supranuclear Palsy.

Authors:  Zulzikry Hafiz Abu Bakar; Tomoko Kato; Daijiro Yanagisawa; Jean-Pierre Bellier; Ken-Ichi Mukaisho; Ikuo Tooyama
Journal:  Acta Histochem Cytochem       Date:  2021-06-23       Impact factor: 1.938

Review 8.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 9.  Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.

Authors:  Alessia Indrieri; Rocco Pizzarelli; Brunella Franco; Elvira De Leonibus
Journal:  Front Neurosci       Date:  2020-10-19       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.